-
Nov 5, 2021, 12:52 pm173 pts
Ars Technica
Enlarge / Pfizer headquarters in Manhattan on November 19, 2020. (credit: Getty | Anadolu Agency) An antiviral pill developed by Pfizer reduced COVID-19 hospitalizations and deaths by about 89 percent in a trial involving 774 newly infected people at risk of developing severe disease. That's according to a…
Trending Today on Tech News Tube
Tech News Tube is a real time news feed of the latest technology news headlines.
Follow all of the top tech sites in one place, on the web or your mobile device.
Follow all of the top tech sites in one place, on the web or your mobile device.
